DisulfiramÄ¡·á ÈÄ ¹ß»ýÇÑ °¡¿ª¿îµ¿½Å°æº´
Reversible Motor Neuropathy Following Disulfiram Therapy

´ëÇѽŰæ°úÇÐȸÁö 2014³â 32±Ç 3È£ p.225 ~ p.227

¹Ú¼±¿ì(Park Sun-Woo) - Á¦ÁÖ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ½Å°æ°úÇб³½Ç
¼Û¼÷±Ù(Song Sook-Keun) - Á¦ÁÖ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ½Å°æ°úÇб³½Ç
ÀÌÁ¤¼®(Lee Jung-Seok) - Á¦ÁÖ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ½Å°æ°úÇб³½Ç
ÃÖÀçö(Choi Jay-Chol) - Á¦ÁÖ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ½Å°æ°úÇб³½Ç
°­ÁöÈÆ(Kang Ji-Hoon) - Á¦ÁÖ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ½Å°æ°úÇб³½Ç
°­»çÀ±(Kang Sa-Yoon) - Á¦ÁÖ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ½Å°æ°úÇб³½Ç

Abstract

Ű¿öµå

Disulfiram, Motor neuropathy, Nerve conduction study
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Ű¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆÇ³âµµ(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå